MACVIA Clinical Decision Algorithm in Allergic Rhinitis in adolescents and adults

Jean Bousquet 1, 2, 3, * Holger J. Schünemann 4 Peter W. Hellings 5 Sylvie Arnavielhe 6 Claus Bachert 7 Anna Bedbrook 1 Karl-Christian Bergmann 8 Sinthia Bosnic-Anticevich 9 Jan Brozek 4 Moises Calderon 10 G. Walter Canonica 11 Thomas B. Casale 12 Niels H. Chavannes 13 Linda Cox 14 Henry Chrystyn 15 Alvaro A. Cruz 16 Ronald Dahl 17 Giuseppe de Carlo 18 Pascal Demoly 19, 20 Philippe Devillier 21 Gérard Dray 22 Monica Fletcher 23 Wytske J. Fokkens 24 Joao Fonseca 25 Sandra N. Gonzalez-Diaz 26 Lawrence Grouse 27 Thomas Keil 28 Piotr Kuna 29 Désirée Larenas-Linnemann 30 Karin C. Lodrup Carlsen 31 Eli O. Meltzer 32 Joaquim Mullol 33 Antonella Muraro 34 Robert Naclerio 35 Susanna Palkonen 18 Nikolaos G. Papadopoulos 36 Giovanni Passalacqua 11 David Price 37 Dermot Ryan 38 Boleslaw Samolinski 39 Glenis K. Scadding 40 Aziz Sheikh 41 Arunas Valiulis 42 Erkka Valovirta 43 Samantha Walker 44 Magnus Wickman 45 Arzu Yorgancioglu 46 Torsten Zuberbier 8
* Corresponding author
1 MACVIA-LR - Contre les MAladies Chroniques pour un VIeillissement Actif en Languedoc-Roussillon
2 VIMA - Vieillissement et Maladies chroniques : approches épidémiologique et de santé publique
3 CHU Saint-Eloi
4 Departments of Clinical Epidemiology and Biostatistics and Medicine [Ontario]
5 Laboratory of clinical immunology
6 Kyomed
7 Upper Airways Research Laboratory
8 GA2LEN - Secretary General of the Global Allergy and Asthma European Network
9 Woolcock Institute of Medical Research [Sydney]
10 NHLBI - National Heart, Lung, and Blood Institute [Bethesda]
11 Allergy & Respiratory Diseases Clinic - DIMI
12 Division of Allergy/Immunology
13 Department of Public Health and Primary Care [leiden]
14 Department of Medicine [Floride]
15 RiRL
16 ProAR – Nucleo de Excelencia em Asma
17 Department of Dermatology and Allergy Centre
18 EFA - European Federation of Allergy
19 DS3 - ESIM - Déterminants Sociaux de la Santé et du Recours aux Soins
20 Service des Maladies Respiratoires [Montpellier]
21 Laboratoire de Pharmacologie Respiratoire UPRES EA220
22 IMT - MINES ALES - IMT - MINES ALES
23 Education for Health
24 Department of Otorhinolaryngology [Amsterdam]
25 CINTESIS - Center of Research in Health Technologies and Information Systems
26 Universidad Autonoma de Nuevo Leon (Monterrey, Mexico)
27 Faculty of the Department of Neurology
28 Institute of Social Medicine
29 Division of Internal Medicine, Asthma and Allergy
30 Clínica de Alergia- Asma y Pediatría
31 Department of Paediatrics [Oslo]
32 Allergy & Asthma Medical Group & Research Center
33 Transverse group for research in primary care [Barcelona]
34 Department of Women and Child Health
35 OHNS - Section of Otolaryngology-Head & Neck Surgery
36 Center for Pediatrics and Child Health
37 Academic Centre of Primary Care
38 Allergy and Respiratory Research Group
39 Department of Prevention of Envinronmental Hazards and Allergology
40 The Royal National TNE Hospital
41 Centre for Population Health Sciences
42 Vilnius University Clinic of Children's Diseases
43 Dept. of Lung Diseases and Clinical Allergology
44 MRC - Asthma UK Centre in Allergic Mechanisms of Asthma, King's College London,
45 IMM - The Institute of Environmental Medicine [Stockholm]
46 Department of Pulmonology
Abstract : The selection of pharmacotherapy for patients with allergic rhinitis depends on several factors, including age, prominent symptoms, symptom severity, control of allergic rhinitis, patient preferences and cost. Allergen exposure and resulting symptoms vary and treatment adjustment is required. Clinical decision support systems (CDSS) may be beneficial for the assessment of disease control. Clinical decision support systems should be based on the best evidence and algorithms to aid patients and health care professionals to jointly determine the treatment and its step-up or step-down strategy depending on AR control. MACVIA-LR (Fighting chronic diseases for active and healthy ageing) one of the reference sites of the European Innovation Partnership on Active and Healthy Ageing, has initiated an allergy sentinel network (MASK: MACVIA-ARIA Sentinel networK). A clinical decision support system is currently being developed to optimize allergic rhinitis control. An algorithm developed by consensus is presented in this paper. This algorithm should be confirmed by appropriate trials.
Keywords : ICT MACVIA-LR conjunctivitis ARIA allergic rhinitis clinical decision support system
Document type :
Journal articles
Complete list of metadatas

Cited literature [18 references]  Display  Hide  Download
https://hal.sorbonne-universite.fr/hal-01310973
Contributor : Gilles d'Eggis <>
Submitted on : Tuesday, May 3, 2016 - 2:41:38 PM
Last modification on : Friday, August 23, 2019 - 3:10:07 PM
Long-term archiving on : Tuesday, May 24, 2016 - 6:25:13 PM

File

1-s2.0-S0091674916301488-main....
Publication funded by an institution

Licence

Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

UPMC | UVSQ | UNIV-PARIS-SACLAY | UNIV-MONTPELLIER | EM-ALES | CNRS | SORBONNE-UNIVERSITE | VIMA | SU-MEDECINE

Citation

Jean Bousquet, Holger J. Schünemann, Peter W. Hellings, Sylvie Arnavielhe, Claus Bachert, et al.. MACVIA Clinical Decision Algorithm in Allergic Rhinitis in adolescents and adults. Journal of Allergy and Clinical Immunology, Elsevier, 2016, ⟨10.1016/j.jaci.2016.03.025⟩. ⟨hal-01310973⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

506

Files downloads

572

Contact

CCSD